Michael Berman
Tel Aviv, Israel
Joined in 2004
Investing in innovation and guiding medical technology companies is the ultimate path to doing well and doing good.
A medical device entrepreneur, Mike works with a select group of high-potential, early-stage companies. As a consultant to RiverVest, Mike provides the firm with advice on existing and potential portfolio companies, especially as it relates to technology being developed in Israel.
Mike was the President of the Boston Scientific Corporation Cardiology business from 1995 to 2000 and is a co-founder of eight medical technology companies including Velocimed, LLC, a former RiverVest Fund I portfolio company acquired by St. Jude Medical, Inc. In addition, he was a founding director of Lutonix, Inc., a former RiverVest Fund II portfolio company acquired by C.R. Bard, Inc. He currently serves as a board member of a number of private and public medical technology companies.
Mike earned an M.B.A. and a B.S. from Cornell University.
Personal Interests: running, mountain biking and skiing
Committed to Doing Business the Right Way to Deliver the Best Outcomes for Patients, Entrepreneurs, and Investors
St. Louis, San Diego & Cleveland
Our Team
A Strong Partnership Built to Last
SchmelterCo-Founder & Managing Director
McKearnManaging Director
O'DonnellManaging Director
MelzerCo-Founder and Managing Director
HongManaging Director
RappManaging Director
SpilizewskiVice President
WeitzmanChief Financial Officer
CatheyDirector of Administration
ZikePrincipal
KroteeSenior Associate
BermanConsultant and Venture Partner
RotherDirector of Finance
HarrisController
KleiboekerAnalyst
SeitzAnalyst
KellerConsultant
ShortExecutive Assistant
Our Team
Scientific Advisors
BorchardtDistinguished Professor Emeritus, The University of Kansas-Lawrence
DiPersioChief, Division of Oncology and Deputy Director, Siteman Cancer Center, Washington University School of Medicine
RaderProfessor, UF Scripps Biomedical Research
RutterProfessor of Biochemistry and HHMI Investigator, University of Utah
SetteProfessor and Member LaJolla Institute for Immunology, Division of Vaccine Discovery Center for Infectious Disease and Vaccine Research
TontonozFrancis and Albert Piansky Professor of Pathology, Professor of Biological Chemistry, University of California, Los Angeles
15 Companies Founded
Collaborative Approach and Open Communication
An exceptional firm culture where each is expected to be transparent, strategic, dependable, results-driven, collaborative, and grounded in purpose. That's RiverVest.